PRNewsWire - Health

Alpha Fusion, Inc. and Curadh MTR, Inc. to Enter into Strategic Partnership to Advance Global Development of Astatine-211 Based Radiopharmaceuticals
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
AbbVie to Host Second-Quarter 2025 Earnings Conference Call
Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)